The NIDDK CCEH consortium provides support for nonmalignant hematology research using pilot and feasibility funds.
Postdocs, with signed approval of their mentor, may apply for support to begin a research track of their own. Investigators with outside funding who want to start a new line of research in nonmalignant hematology can apply provided there is no overlap between their funded research and the proposal submitted for this mechanism. Preference will be given to junior investigators who are requesting support for a project that will generate preliminary data for use in an application for an NIDDK Hematology award (either F-series, K-series or research project grant). Depending on the nature of preliminary studies, two different P&F opportunities are available:
Type A: $5-20K short-term awards to support use of state-of-the-art CCEH core facilities and acquisition of new skill sets needed for competitive grants. For trainees, sign off by the lab PI is required.
Type B: $75K Pilot research projects to generate preliminary data in support of novel concepts and new directions in hematology. Applications that propose to use one or more of the CCEH cores are welcome.
Research proposed must be within the mission of NIDDK Hematology (https://www.niddk.nih.gov/research-funding/research-programs#hematologic-diseases).
The grants will be awarded competitively and will undergo a peer review coordinated by the NIDDK Hematology Central Coordinating Center (HCCC). Rankings will be based on significance, innovation, approach, feasibility, and the prospect of the applicant obtaining subsequent extramural funding to continue the line of research.
Applications for Type A projects will be accepted on a rolling basis through December 1, 2020.
Applications for Type B projects are due by October 1, 2020.
New applications, only, should be uploaded as a single PDF file (11-point Arial font size and 0.5” margins) that must include:
New applications, only, should be uploaded as a single PDF file (11-point Arial font size and 0.5” margins).
Use the PHS 398 form (https://grants.nih.gov/grants/funding/phs398/phs398.html) including face, abstract, detailed budget, biographical and other support pages, and research plan. The research plan is limited to 5 pages and should include the following sections:
Extensive preliminary data on this project is an indication that the project is beyond the scope of this FOA.
Budgets are limited to $75,000 total costs (inclusive of all F&A costs) and will be administered as a subaward to an active NIDDK Hematology Centers grant. If in-kind services from a CCEH are proposed, the total costs for the award should be reduced by the negotiated costs of the in-kind services.
Please upload a single PDF of your application to www.cceh.io/funding
For questions about application submission and receipt, please contact John Phillips: email@example.com
For scientific questions, please contact Shilpa Hattangadi: firstname.lastname@example.org
DIRECTIONS TO START THE APPLICATION PROCESS for Type A or Type B P&F Proposals
1. Check guidelines for eligibility.
a. Priority will be given to Junior Investigators and Postdocs.
b. Established Investigators starting a new line of Research in nonmalignant hematology - cannot be focused on currently funded project
2. Determine the type of grant you wish to apply for.
a. Type A - Core Usage Funds Only (C-UFO) up to $20,000 (no F&A, funds made available only at Core proposed).
Due on rolling basis until Dec 1, 2020.
b. Type B - New Pilot Proposal (HCCC-P&F) up to $75,000 including recommended F&A (Use PHS 398 forms as detailed).
Due Oct 1, 2020
3. Contact core director(s) of the core you will be using to initiate guidance on feasibility and costs associated with core use.
4. Write and submit proposals as a single PDF using the detailed guidelines on length and inclusions on the FUNDING link cceh.io/funding (“red” Submit box) prior to final due date and time.
No applications will be accepted after 5pm MST on the due date.
John Phillips, Diane Ward
Last updated: 09-01-2020